One analyst thinks this buy-the-dip favorite from the regional bank crisis may be a value trap
Redburn analyst Charles Bendit downgraded Charles Schwab to sell from neutral, saying that rate hikes and regulatory uncertainty are short-term headwinds.
DOJ charges 18 people — including doctors — in massive Covid health-care fraud takedowns
The alleged health-care fraud schemes involved false billing and theft from federal programs, fake Covid vaccine cards, and Covid test kits.
Retail traders are dumping tech stocks, but loading up on this one big bank
Retail traders pivoted away from big tech names in favor of financials.
Biden pledges $500 million to fight Amazon deforestation, but Congress must approve
The president, during a virtual meeting with the Major Economies Forum on Energy and Climate, also pledged $1 billion to the Green Climate Fund.
U.S. trains keep derailing. Why?
Regulators are scrutinizing the freight rail industry as total reported derailments rose year over year to 916 in 2022 amid a decadelong decline.
Analysts really like this fast casual chain into earnings
The fast casual chain is set to report results on Apr. 25.
Oppenheimer says this small cap AI pure play is set for a big rally
Oppenheimer initiated an overweight rating and $37 price target on PROS shares. The firm says it’s approaching long-term growth profitability.
Moderna teams up with IBM to put A.I., quantum computing to work on mRNA technology used in vaccines
Moderna’s partnership with IBM comes as the drugmaker navigates its post-pandemic boom driven by its mRNA Covid vaccine.
Home sales fell in March amid volatility in mortgage rates
Sales of previously owned homes declined 2.4% in March compared with February, according to the National Association of Realtors.
Appeals court temporarily blocks House subpoena for ex-Manhattan prosecutor in Trump probe
The former Manhattan prosecutor Mark Pomerantz was involved in a criminal investigation of ex-President Donald Trump.
